Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $169 at UBS

August 5, 2020 7:11 AM
UBS raised its price target on Zimmer Biomet (NYSE: ZBH) to $169.00 (from $165.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles